Health Care & Life Sciences » Pharmaceuticals | AcelRx Pharmaceuticals Inc.

AcelRx Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
29,502.00
5,217.00
19,263.00
17,357.00
7,995.00
2,151
Cost of Goods Sold (COGS) incl. D&A
593.00
-
2,762.00
12,315.00
10,659.00
3,976
Gross Income
28,909.00
-
16,501.00
5,042.00
2,664.00
1,825
SG&A Expense
35,576.00
42,000.00
35,699.00
36,999.00
36,018.00
33,902
EBIT
6,667.00
37,649.00
19,198.00
31,957.00
38,682.00
35,727
Unusual Expense
15,273.00
7,586.00
1,344.00
600.00
95.00
86
Non Operating Income/Expense
32.00
651.00
380.00
318.00
415.00
1,052
Interest Expense
1,518.00
2,639.00
5,405.00
12,152.00
14,037.00
12,558
Pretax Income
23,426.00
33,353.00
23,639.00
43,191.00
52,209.00
47,147
Income Tax
-
-
760.00
34.00
701.00
2
Consolidated Net Income
23,426.00
33,353.00
24,399.00
43,157.00
51,508.00
47,149
Net Income
23,426.00
33,353.00
24,399.00
43,157.00
51,508.00
47,149
Net Income After Extraordinaries
23,426.00
33,353.00
24,399.00
43,157.00
51,508.00
47,149
Net Income Available to Common
23,426.00
33,353.00
24,399.00
43,157.00
51,508.00
47,149
EPS (Basic)
0.59
0.91
0.60
0.95
1.10
0.81
Basic Shares Outstanding
39,746.70
43,427.10
44,300.10
45,313.10
46,883.50
58,408.50
EPS (Diluted)
0.59
0.91
0.60
0.95
1.10
0.81
Diluted Shares Outstanding
39,746.70
44,322.30
44,468.40
45,313.10
46,883.50
58,408.50
EBITDA
6,074.00
36,783.00
17,214.00
29,905.00
36,938.00
35,152

About AcelRx Pharmaceuticals

View Profile
Address
351 Galveston Drive
Redwood City California 94063
United States
Employees -
Website http://www.acelrx.com
Updated 07/08/2019
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of acute pain. Its products include DSUVIA and ZALVISO. The company was founded by Thomas A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.